KRAS and lung adenocarcinoma: Because mutations in oncogenes such as EGFR and KRAS have been shown to occur in lung adenocarcinoma, the presence of KRAS and EGFR mutations in CMPTs has been hypothesized to be associated with lung adenocarcinoma by some investigators.7, 10, 14